Metanephric mesenchyme development

pathway activity — cross-omics
GO:0072075Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Metanephric mesenchyme development pathway is significantly associated with the protein abundance of multiple proteins, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are ZYX, UBR5, and LMOD1, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Metanephric mesenchyme development activity versus ZYX in LSCC (Pearson r = -0.35).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCZYX →-0.187-0.070.003<.00137
LSCCUBR5 →+0.206+0.078.001.00136
CCRCCLMOD1 →-0.746-0.065.003.00636
BRCAMSRB3 →-0.445-0.048.006.00236
UCECTBC1D13 →-0.327-0.117.001<.00136
LSCCMORC2 →+0.352+0.084<.001<.00136
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0072075 vs ZYX — LSCC

Per-sample scatter of Metanephric mesenchyme development activity vs ZYX in LSCC.

Explore this scatter interactively →

Exploration